Background: Recent reductions in Official Development Assistance (ODA) have raised concerns about their potential impact on health in low- and middle-income countries (LMICs). We aimed to assess the impact of reductions in ODA from 11 major donor European countries on mortality in LMICs through 2030.Methods: We conducted a modelling study using country-level data on ODA disbursements and published estimates of the association between ODA and mortality. We estimated changes in averted deaths using the preventable fraction of the population under two scenarios: a reference scenario in which ODA funding is maintained at previous peak levels, and a reduction scenario based on recent declines and projected trends through 2030. Uncertainty intervals were derived using Monte Carlo simulations. Results: ODA disbursements varied across donor countries and over time, with heterogeneous timing of peak funding and subsequent reductions. Reductions in ODA were associated with decreases in potential averted deaths across all donors. The largest estimated excess deaths under the reduction scenario, compared with the reference scenario, were observed for the United Kingdom (4,304,844 additional deaths [95% Uncertainty Intervals - UI: 1,673,595–6,840,258]), followed by France (3,017,695 [95%UI:1,271,946–4,771,584]) and Germany (2,823,230 [95%UI:1,242,110–4,394,089]). Findings were consistent across modelling approaches. Interpretation: Reductions in ODA from European donors may translate into millions of avoidable deaths in LMICs by 2030, even if funding stabilizes over the coming years. These findings underscore the importance of sustained humanitarian and development assistance and highlight the toll of abrupt funding cuts.